Nkarta Announces November & December 2020 Investor Conference Schedule
Nkarta, a clinical-stage biopharmaceutical company focused on developing engineered natural killer (NK) cell therapies for cancer, has announced its participation in several upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nkarta, a clinical-stage biopharmaceutical company focused on developing engineered natural killer (NK) cell therapies for cancer, has announced its participation in several upcoming investor conferences.
The events include:
- Cowen 2020 IO Next Summit on November 13, 2020, at 11:45 a.m. ET
- Stifel 2020 Virtual Healthcare Conference on November 17, 2020, at 2:00 p.m. ET
- Evercore ISI 3rd Annual HealthCONx Conference on December 1, 2020, at 9:40 a.m. ET
Audio webcasts will be available on Nkarta's website, with replays archived for about four weeks.
Positive
- Participation in multiple investor conferences may enhance visibility and attract potential investors.
Negative
- None.
Details
News Market Reaction – NKTX
The recorded move for NKTX in the trading session of this news was -4.91%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at these upcoming investor conferences:
Cowen 2020 IO Next Summit
Date: Friday, November 13, 2020
Fireside chat presentation: 11:45 a.m. ET
Stifel 2020 Virtual Healthcare Conference
Date: Tuesday, November 17, 2020
Fireside chat presentation: 2:00 p.m. ET
Evercore ISI 3rd Annual HealthCONx Conference
Date: Tuesday, December 1, 2020
Fireside chat presentation: 9:40 a.m. ET
A live audio webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com. A replay of the webcast will be archived on the website for approximately four weeks.
About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.
Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.